Coronary flow slows as renal function worsens

Clinical Cardiology

Volumn 32, Issue 5, 2009, Pages 278-282

  Yilmaz, Mehmet Birhan ^a,b   Yalta, Kenan ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE;

CASE-CONTROL STUDIES; CORONARY CIRCULATION; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; STATISTICS AS TOPIC;

EID: 66449095281     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20387     Document Type: Article

References (14)

1. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL. Seven year survival of patients with normalor near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol. 1986;7:479-483. (Pubitemid 16164373)
2. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93:879-888. (Pubitemid 26074824)
3. Kern MJ, Moore JA, Aguirre FV, et al. Determination of angiographic (TIMI grade) blood flow by intracoronary Doppler flow velocity during acute myocardial infarction. Circulation. 1996;94:1545-1552. (Pubitemid 26320256)
4. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium [review]. N Engl J Med. 1990;323:27-36. (Pubitemid 20209469)
5. Palmer RMJ, Ferridge AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526. (Pubitemid 17085822)
6. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci. 1999;55:1078-1087. (Pubitemid 29361074)
7. Kari JA, Donald AE, Vallance DT, et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 1997;52:468-472. (Pubitemid 27359590)
8. Zoccali C, Bode-Boger S, Mallamaci F, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001;358:2113-2117. (Pubitemid 34094901)
9. Kang YS, Han KH, Han SY, Kim HK, Cha DR. Characteristics of population with normal serum creatinine impaired renal function and: the validation of a MDRD formula in a healthy general population. Clin Nephrol. 2005;63:258-266. (Pubitemid 40542385)
10. Hermenegildo C, Medina P, Peiro M, et al. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients. J Clin Endocrinol Metab. 2002;87:5636-5640. (Pubitemid 36034371)
11. Sarnak MJ, Levey AS, Schoolwerth AC, et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-2169.
12. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-575.
13. Pekdemir H, Cin VG, Cicek D, et al. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol. 2004;59:127-133. (Pubitemid 38506580)
14. Potkin BN, Bartorelli AL, Gessert JM, et al. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation. 1990;81:1575-1585. (Pubitemid 20158297)